This funding opportunity supports early-stage projects developing innovative technologies that enhance molecular or cellular characterization of cancer or improve biospecimen handling and quality control. It funds proof-of-concept studies testing technical feasibility of new methods, tools, assays, platforms, or instruments focused on cancer-relevant applications. Clinical trials are not allowed. Eligible applicants include a wide range of domestic and foreign organizations.
Eligible applicants include nonprofits, small businesses, private and public institutions of higher education, tribal organizations, government entities, and foreign organizations. Both domestic and non-domestic entities may apply, including foreign components of U.S. organizations.
